These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35745077)

  • 21. Cyrene™ as an Alternative Sustainable Solvent for the Preparation of Poly(lactic-co-glycolic acid) Nanoparticles.
    Grune C; Thamm J; Werz O; Fischer D
    J Pharm Sci; 2021 Feb; 110(2):959-964. PubMed ID: 33275992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles using sodium carboxymethyl cellulose as colloidal stabilize.
    Chittasupho C; Thongnopkoon T; Kewsuwan P
    Curr Drug Deliv; 2016; 13(1):95-104. PubMed ID: 26338259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
    Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
    AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved oral delivery of insulin by PLGA nanoparticles coated with 5
    Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L
    Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving cellular uptake and cytotoxicity of chitosan-coated poly(lactic-
    Van Hees S; Elbrink K; De Schryver M; Delputte PL; Kiekens F
    Nanomedicine (Lond); 2020 Nov; 15(27):2671-2688. PubMed ID: 33112210
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhanced antitumor activity in A431 cells via encapsulation of 20(R)-ginsenoside Rg3 in PLGA nanoparticles.
    Zhang S; Liu J; Ge B; Du M; Fu L; Fu Y; Yan Q
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1734-1741. PubMed ID: 28581836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of camptothecin-encapsulated poly(lactic-
    Bao H; Zhang Q; Yan Z
    Int J Nanomedicine; 2019; 14():383-391. PubMed ID: 30662262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zinc phthalocyanine tetrasulfonate-loaded polyelectrolytic PLGA nanoparticles for photodynamic therapy applications.
    de Toledo MCMC; Abreu ADS; Carvalho JA; Ambrósio JAR; Godoy DDS; Dos Santos Pinto BC; Beltrame Junior M; Simioni AR
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101966. PubMed ID: 32835878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.
    Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H
    Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.
    Kashi TS; Eskandarion S; Esfandyari-Manesh M; Marashi SM; Samadi N; Fatemi SM; Atyabi F; Eshraghi S; Dinarvand R
    Int J Nanomedicine; 2012; 7():221-34. PubMed ID: 22275837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
    Mosafer J; Teymouri M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.
    Hussein AS; Abdullah N; Ahmadun FR
    IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
    Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
    Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics.
    Jeon HJ; Jeong YI; Jang MK; Park YH; Nah JW
    Int J Pharm; 2000 Oct; 207(1-2):99-108. PubMed ID: 11036235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.